PPARA and systemic lupus erythematosus: Peyer’s patches transcriptome results showed that pups that acquired FN041 by intervention mode I activated retinol metabolism, the PPAR signaling pathway and inhibited asthma, type I diabetes mellitus, systemic lupus erythematosus and autoimmune thyroid disease pathways.